Immunohistochemical studies have shown
E-cadherin to be expressed in
breast carcinomas showing a ductal histology, with a corresponding loss of expression in
tumors with a lobular histology. As a result, mouse monoclonal anti-
E-cadherin [HECD-1] has been used by pathologists to differentiate between ductal and
lobular carcinomas, with currently published sensitivity and specificity rates of approximately 90%. Rabbit
monoclonal antibodies may combine the best properties of both mouse
monoclonal antibodies and rabbit
antisera. Therefore, this study compares the staining sensitivity and specificity of a new rabbit monoclonal
E-cadherin and the standard mouse monoclonal
E-cadherin [HECD-1] in breast
ductal carcinomas, and evaluates a cocktail of rabbit monoclonal
E-cadherin and p120
catenin in the discrimination of ductal from
lobular carcinomas. The rabbit
E-cadherin showed sharper staining and increased sensitivity (80/81, 99%) than the mouse
E-cadherin (75/81, 93%). The rabbit
E-cadherin achieved a score of 3+ in 85.2% (69/81) of cases as compared with a 3+ in only 21.0% (17/81) of cases stained with mouse
E-cadherin. All
lobular carcinomas (n=37) were confirmed by the absence of
E-cadherin and the diffuse cytoplasmic expression of p120
catenin. Although both the single mouse
E-cadherin and dual
stain can differentiate ductal from lobular lesions, the dual
stain is helpful in challenging cases because of its bright pink p120
catenin and dark brown rabbit
E-cadherin staining. The highly sensitive rabbit
E-cadherin antibody is the preferred antibody for evaluating
ductal carcinomas and for distinguishing ductal versus lobular lesions, and the dual
stain was superior to the single
E-cadherin stain.